chevron_leftBack
As of 20 June 2026, Panchsheel Organics Ltd. has a market cap of $15.88M USD, ranking #38622 globally and #2850 in India.
It ranks #3454 in the Healthcare sector, and #1137 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$15.88MUSD
1.5B INR
Enterprise Value
$15.9MUSD
1.5B INR
Revenue (TTM)
$10.95MUSD
1.03B INR
EBITDA (TTM)
$1.57MUSD
148.03M INR
Net Income (TTM)
$1.28MUSD
120.4M INR
EBITDA Margin
14%
Profit Margin
12%
PE Ratio
12.5
PS Ratio
1.5
PB Ratio
1.1
EV/EBITDA
10.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mahendra Turakhia
open_in_new
Employees
185
Founded
1989
Website
panchsheelorganics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2% | -4.6% | 15% | 9.4% | -17% | -21% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
531726
(PANCHSHEEL)
Panchsheel Organics Ltd
ISIN: INE316G01019
Shares Out.:
Shares Outstanding:
13.172M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
113.82 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Panchsheel Organics Ltd.
Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Organics Limited was incorporated in 1989 and is based in Mumbai, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
285K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
116K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
95K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
74K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
62K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
61K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
5M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
3M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
2M%
|
97.4
|
|
SIX: RO
|
$318.3B
2M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
2M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
2M%
|
15.1
|
chevron_leftBack